Teri Jones Heiland
Gründer bei Immunomic Therapeutics, Inc.
Profil
Teri Jones Heiland is the founder of Capital Genomix, Inc., Immunomic Therapeutics, Inc. She previously worked as a Senior Scientist at Kirkegaard & Perry Laboratories, Inc. She holds a doctorate degree from the University of Missouri, which she received in 1993.
Aktive Positionen von Teri Jones Heiland
| Unternehmen | Position | Beginn |
|---|---|---|
Immunomic Therapeutics, Inc.
 Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Gründer | - |
Ehemalige bekannte Positionen von Teri Jones Heiland
| Unternehmen | Position | Ende |
|---|---|---|
Kirkegaard & Perry Laboratories, Inc.
 Kirkegaard & Perry Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Part of LGC Ltd., Kirkegaard & Perry Laboratories, Inc. develops, manufactures, and markets immunochemicals. The company is based in Gaithersburg, MD. Kirkegaard & Perry Laboratories was acquired by SeraCare Life Sciences, Inc., part of LGC Ltd. from November 26, 2018 on August 19, 2013. | Technik-/Wissenschafts-/F&E-Leiter | - |
Capital Genomix, Inc.
 Capital Genomix, Inc. Medical SpecialtiesHealth Technology Capital Genomix, Inc. develops and markets novel antibody based therapeutics. The firm possesses two genomic and proteomic drug development technology platforms, GeneSystem320 and ImmunoMouse. The company was founded in August 2000 and is headquartered in Gaithersburg, MD. | Gründer | - |
Ausbildung von Teri Jones Heiland
| University of Missouri | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Health Technology |
Capital Genomix, Inc.
Capital Genomix, Inc. Medical SpecialtiesHealth Technology Capital Genomix, Inc. develops and markets novel antibody based therapeutics. The firm possesses two genomic and proteomic drug development technology platforms, GeneSystem320 and ImmunoMouse. The company was founded in August 2000 and is headquartered in Gaithersburg, MD. | Health Technology |
Kirkegaard & Perry Laboratories, Inc.
Kirkegaard & Perry Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Part of LGC Ltd., Kirkegaard & Perry Laboratories, Inc. develops, manufactures, and markets immunochemicals. The company is based in Gaithersburg, MD. Kirkegaard & Perry Laboratories was acquired by SeraCare Life Sciences, Inc., part of LGC Ltd. from November 26, 2018 on August 19, 2013. | Process Industries |
